Invention Grant
- Patent Title: Oral drug dosage forms compromising a fixed-dose of an ADHD non-stimulant and an ADHD stimulant
-
Application No.: US16960867Application Date: 2018-12-25
-
Publication No.: US11571391B2Publication Date: 2023-02-07
- Inventor: Feihuang Deng , Xiaoling Li , Senping Cheng , Ying Wang , Qing Luo
- Applicant: Triastek, Inc.
- Applicant Address: CN Nanjing
- Assignee: Triastek, Inc.
- Current Assignee: Triastek, Inc.
- Current Assignee Address: CN Nanjing
- Agency: Morrison & Foerster LLP
- Priority: WOPCT/CN2018/071966 20180109
- International Application: PCT/CN2018/123400 WO 20181225
- International Announcement: WO2019/137200 WO 20190718
- Main IPC: A61K9/20
- IPC: A61K9/20 ; B33Y70/00 ; B33Y80/00 ; A61K31/137 ; A61K31/155 ; A61K31/4168 ; A61K31/4458 ; B33Y10/00

Abstract:
The present disclosure provides oral drug dosage forms comprising: (a) an erodible non-stimulant material admixed with an ADHD non-stimulant; and (b) an erodible stimulant material admixed with an ADHD stimulant, wherein the erodible non-stimulant material admixed with the ADHD non-stimulant is embedded in a substrate material, and wherein upon exposure to gastrointestinal fluid the ADHD non-stimulant is released according to a desired non-stimulant release profile and the ADHD stimulant is released according to a desired stimulant release profile. In some embodiment, the ADHD non-stimulant is released according to a sustained release profile. In some embodiments, the ADHD stimulant is released according to an immediate release profile. The oral drug dosage forms of the present disclosure are useful for the treatment of attention deficit hyperactivity disorder (ADHD). Also provided herein are methods of designing and manufacturing the oral drug dosage forms described herein.
Public/Granted literature
- US20210077410A1 ORAL DRUG DOSAGE FORMS COMPROMISING A FIXED-DOSE OF AN ADHD NON-STIMULANT AND AN ADHD STIMULANT Public/Granted day:2021-03-18
Information query